Lumida
/NATR
⌘K
Nature's Sunshine Products Inc

Nature's Sunshine Products Inc

NATR
$13.55USD-0.44%-0.06 today

MARKET CAP

238.4M

P/E (TTM)

12.3x

FWD P/E

DAY RANGE

$13 – $14

52W RANGE

$13
$28

AI Summary

Stalk
TrimMedium

Personal Care Products remains in a clear Stage 4 decline with a support failure signaling accelerating downside. Medium-term bias is bearish, and while the long-term trend is still up, the current momentum and lack of mean-reversion eligibility disallow fresh buys. With price deeply extended below EMAs and in oversold territory, we will Trim into any relief rallies rather than aggressively sell into exhaustion.

  • Q2 net sales hit $117 M (+2% YoY) with strong 73.7% gross margin
  • New CFO and North America EVP to drive efficiency and growth
  • 2026 guidance cut due to foreign exchange and China market pressures
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$444.1M$421.9M$445.3M$454.4M$480.1M
YoY %+15.3%-5.0%+5.5%+2.0%+5.7%
P / Sales0.8x0.4x0.8x0.6x0.8x
EV / Sales0.9x0.4x0.8x0.6x0.8x
Gross Profit, Adj.$328.6M$299.8M$321.1M$324.7M$347.7M
YoY %+15.7%-8.8%+7.1%+1.1%+7.1%
Margin %74.0%71.0%72.1%71.5%72.4%
EV / Gross Profit1.2x0.6x1.1x0.8x1.2x
EBITDA, Adj.$45.8M$27.3M$30.6M$34.3M$38.6M
YoY %+42.2%-40.5%+12.0%+12.3%+12.5%
Margin %10.3%6.5%6.9%7.6%8.0%
EV / EBITDA8.5x6.9x11.6x8.0x10.5x
EBIT$34.7M$16.3M$18.7M$20.1M$24.7M
YoY %+61.4%-53.1%+15.3%+7.2%+23.1%
Margin %7.8%3.9%4.2%4.4%5.2%
EV / EBIT11.2x11.5x18.8x13.7x16.3x
Net Income$28.9M$-390,000$15.1M$7.7M$19.5M
YoY %+35.2%-101.4%+3965.6%-49.0%+153.7%
Net Margin6.5%-0.1%3.4%1.7%4.1%
EPS (GAAP)$1.42-$0.02$0.77$0.40$1.06
YoY %+32.7%-101.4%+3950.0%-48.1%+165.0%